EarCentric EX2 vs RxEars Rxi

The EarCentric EX2 is a budget-priced prescription behind-the-ear hearing aid released in 2021, earning a C grade with a SoundScore of 2.7/5 in HearAdvisor's lab testing. At $218, it ranks #33 of 36 prescription hearing aids tested, placing it in the bottom 11% of its category. In our testing, the EX2 showed a significant split in performance. Feedback handling was excellent at 4.7/5, essentially matching the category average and demonstrating stable operation during movement. However, speech performance was notably limited, with both speech in quiet and speech in noise scoring 1.0/5—well below the category averages of 3.32 and 1.96 respectively. Music streaming scored 0.0/5, falling 2.64 points below the prescription category average of 2.64/5. Own-voice comfort scored 2.3/5, a mixed result that sits 0.45 points below the category average. The device uses a rechargeable battery, which adds convenience for daily use. Notably, tuning did not improve performance in our testing—the Initial and Tuned fit scores were identical at 2.7/5. Budget-conscious shoppers in this price range may want to compare alternatives. The RxEars Rxi scored 4.09/5 at a similar price point, while OTC options like the Audien Hearing Atom offer comparable or better sound performance at lower prices. The EX2 may suit users who prioritize feedback stability and rechargeable convenience over speech clarity, but its limited speech performance is a significant tradeoff.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.